Author

HyunSeung Lee

Observed names: Hyunseung Lee, Lee, HyunSeung

Institution: Celltrion (South Korea)

Observed institution: Celltrion (South Korea)

ORCID: 0009-0005-8360-4559

Observed ORCID: 0009-0005-8360-4559

OpenAlex ID: A5115866401

Usability, efficacy, and safety of candidate tocilizumab biosimilar CT-P47 self-administration via auto-injector and pre-filled syringe in patients with rheumatoid arthritis: a single-arm, open-label, phase 3 study

2025 · Gerd Burmester, Piotr Adrian Klimiuk, et al. · Expert Review of Clinical Immunology · 4

Efficacy and Safety of CT‐P43, a Candidate Ustekinumab Biosimilar, in Moderate‐to‐Severe Plaque Psoriasis: 52‐Week Results From a Randomised, Active‐Controlled, Double‐Blind, Phase III Study

2026 · Kim A. Papp, Janusz Jaworski, et al. · Dermatologic Therapy

Works count: 3

Citation count: 4

H-index: 1

I10-index: